MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)
NCT07042945
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infection
Interventions
DRUG:
MK-4646
Sponsor
Merck Sharp & Dohme LLC